Analyst Ratings for Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (CBD)

Updated: 2017-07-27

Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (NYSE:CBD) was awarded an average rating of Overweight from investment analysts following the stock. A consensus rating of Overweight was previously issued for CBD last month.

A buy rating was issued by 8 analysts, 0 gave an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

CBD was given price targets by several analysts. The most optimistic analyst gave a price target of 27.88, implying potential capital gains of 22.77 percent. The lowest price target was 21.17, implying potential capital losses of -6.78 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 250 percent on average, compared to last month. That number becomes 0 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised downwards by -0.94 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.14 percent.

People are often interested in whether analysts were united in the direction of their revisions. 1 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts decreased their estimates.

In the trailing 52-weeks, CBD hit 24.75 at the highest peak, while it's lowest trading point was 14.08. Today's price is 61.29 percent above the 52-week low, and 8.24 percent lower than its 52-week high. CBD has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The CBD value stock report compares CBD to some of its peers using value stock charts. The market cap of CBD is $5.18 billion. CBD's next earnings release will be on 0000-00-00, which is days away.